GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panion & Bf Biotech Inc (TPE:1760) » Definitions » Cyclically Adjusted PB Ratio

Panion & Bf Biotech (TPE:1760) Cyclically Adjusted PB Ratio : 5.30 (As of Jun. 24, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Panion & Bf Biotech Cyclically Adjusted PB Ratio?

As of today (2024-06-24), Panion & Bf Biotech's current share price is NT$97.50. Panion & Bf Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was NT$18.41. Panion & Bf Biotech's Cyclically Adjusted PB Ratio for today is 5.30.

The historical rank and industry rank for Panion & Bf Biotech's Cyclically Adjusted PB Ratio or its related term are showing as below:

TPE:1760' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.11   Med: 6.41   Max: 10.96
Current: 5.39

During the past years, Panion & Bf Biotech's highest Cyclically Adjusted PB Ratio was 10.96. The lowest was 5.11. And the median was 6.41.

TPE:1760's Cyclically Adjusted PB Ratio is ranked worse than
80.95% of 656 companies
in the Biotechnology industry
Industry Median: 1.615 vs TPE:1760: 5.39

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Panion & Bf Biotech's adjusted book value per share data for the three months ended in Mar. 2024 was NT$21.363. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$18.41 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Panion & Bf Biotech Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Panion & Bf Biotech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panion & Bf Biotech Cyclically Adjusted PB Ratio Chart

Panion & Bf Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 11.30 6.33

Panion & Bf Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.02 7.98 5.91 6.33 5.98

Competitive Comparison of Panion & Bf Biotech's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Panion & Bf Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panion & Bf Biotech's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panion & Bf Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Panion & Bf Biotech's Cyclically Adjusted PB Ratio falls into.



Panion & Bf Biotech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Panion & Bf Biotech's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=97.50/18.41
=5.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panion & Bf Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Panion & Bf Biotech's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=21.363/131.7762*131.7762
=21.363

Current CPI (Mar. 2024) = 131.7762.

Panion & Bf Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201206 4.804 96.819 6.539
201212 4.536 96.871 6.170
201306 4.401 98.518 5.887
201312 9.640 98.326 12.920
201406 9.837 100.560 12.891
201412 10.394 99.070 13.825
201506 10.352 100.684 13.549
201512 11.223 99.792 14.820
201606 10.632 101.688 13.778
201609 0.000 101.861 0.000
201612 11.663 101.863 15.088
201703 0.000 102.862 0.000
201706 11.463 103.349 14.616
201709 11.869 104.136 15.019
201712 12.080 104.011 15.305
201803 16.962 105.290 21.229
201806 16.005 106.317 19.838
201809 16.198 106.507 20.041
201812 17.342 105.998 21.560
201903 17.947 107.251 22.051
201906 16.727 108.070 20.396
201909 16.807 108.329 20.445
201912 17.459 108.420 21.220
202003 15.736 108.902 19.041
202006 15.458 108.767 18.728
202009 15.451 109.815 18.541
202012 15.923 109.897 19.093
202103 14.960 111.754 17.640
202106 15.853 114.631 18.224
202109 22.576 115.734 25.705
202112 22.545 117.630 25.256
202203 21.647 121.301 23.516
202206 23.533 125.017 24.805
202209 24.545 125.227 25.829
202212 23.410 125.222 24.635
202303 21.670 127.348 22.424
202306 21.852 128.729 22.369
202309 22.026 129.860 22.351
202312 22.290 129.419 22.696
202403 21.363 131.776 21.363

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Panion & Bf Biotech  (TPE:1760) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Panion & Bf Biotech Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Panion & Bf Biotech's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Panion & Bf Biotech (TPE:1760) Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 16th Floor, F Building, Nangang District, Taipei, TWN, 11503
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. It is engaged in research and development of pharmaceuticals and new drugs. It focuses on pharmaceuticals, cosmeceuticals, nutraceuticals, and medical devices sectors. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has two geographic segments Taiwan segment and China, Hong Kong, and Macau segment. It generate majority of the revenue from Taiwan segment.

Panion & Bf Biotech (TPE:1760) Headlines

No Headlines